We sure lucked out with Planet Earth. Blue skies, rolling hills, water everywhere. But our home didn't come like this out of the box. Earth was a real fixer-upper, and it took some seriously hard work to build this paradise. Nearly four billion years of renovation. Some tiny, some huge, to make this house a home. Creatures on Earth don't just live and die. They actually change the world around them.
The story of how for nearly 4 billion years, microbes, plants and animals have emerged and sculpted the planet's surface and atmosphere in the strangest of ways.

Morgan Freeman travels the world to study the cycles of war and peace. From the ritualized combat of the sacred Tinku festival in Bolivia to Rwanda's post-genocide reconciliation program, this episode deals with humanity's enormous capacity for violence and the endless pursuit of harmony. Conflict can drive innovation, but is war necessary?

Can love change the world? Morgan Freeman is on a global quest to understand how this primal force binds us together as a species. From orphanages to battlefields, from arranged marriages to life on the streets, Freeman sees how love can be found in unexpected places and how this force inspires us all.

Can we bridge the divide between 'us' and 'them'? At a time when the whole world seems to be polarizing into irreconcilable camps, Morgan Freeman sets out on a journey in search of the forces that push us apart, from intolerance of differences to fear of outsiders, and the possibilities of coming together.

Can we find a way to distribute power so that everyone has their say? A U.S. president explains the challenges of making decisions that affect hundreds of millions of lives, and Freeman learns about an African woman who has created a society without men. He explores how the rise of the internet may fundamentally change how democracy works.

Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.